OKYO Pharma CEO Buys Shares
Ticker: OKYO · Form: 6-K · Filed: Jan 31, 2025 · CIK: 1849296
Sentiment: bullish
Topics: insider-buy, ceo-purchase, biotech
TL;DR
OKYO CEO bought 10k shares at $1.04 on Jan 31st.
AI Summary
On January 31, 2025, OKYO Pharma Ltd announced that its CEO, Gary S. Jacob, purchased 10,000 ordinary shares on NASDAQ at $1.04 per share. This purchase was made through his personal account.
Why It Matters
Insider buying can signal confidence from leadership in the company's future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of insider share purchases, which typically carries low risk.
Key Numbers
- 10,000 — Shares Purchased (CEO Gary S. Jacob bought this many shares.)
- $1.04 — Price Per Share (The price at which the CEO purchased shares.)
Key Players & Entities
- OKYO Pharma Ltd (company) — Registrant
- Gary S. Jacob (person) — Chief Executive Officer
- 10,000 (dollar_amount) — Number of shares purchased
- US$1.04 (dollar_amount) — Price per share
- January 31, 2025 (date) — Date of purchase
FAQ
Who purchased the shares?
Gary S. Jacob, the Chief Executive Officer of OKYO Pharma Ltd.
How many shares were purchased?
10,000 ordinary shares were purchased.
What was the purchase price per share?
The purchase price was US$1.04 per share.
On what date did the purchase occur?
The purchase occurred on January 31, 2025.
Where were the shares purchased?
The shares were purchased on NASDAQ.
Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 12.4 · Accepted 2025-01-31 07:00:25
Key Financial Figures
- $1.04 — dinary shares on NASDAQ at a price of US$1.04 per share. We have also been notified t
Filing Documents
- form6-k.htm (6-K) — 22KB
- ex99-1.htm (EX-99.1) — 9KB
- ex99-1_001.jpg (GRAPHIC) — 30KB
- 0001493152-25-004335.txt ( ) — 74KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. OKYO Pharma LTD Date: January 31, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 3 EXHIBIT INDEX Exhibit No. Description 99.1 News Announcement, dated January 31, 2025 4